Cancer and COVID-19: Conversations from the Front Line is a new video series hosted by Dr. David Ryan, Chief of Hematology/Oncology and Clinical Director of the Mass General Cancer Center.
The videos provide a behind the scenes look at the lives of our front line physicians, researchers, and nurses during the time of COVID-19.
View the videos below, or view the playlist on the Cancer Center's YouTube channel.
Dr. David Ryan speaks with Bob Herman, Senior Director of the Protocol Office at Mass General Cancer Center. Bob oversees a staff of 250 people who ensure patients have access to the latest cutting edge therapies available through clinical trials.
Dr. Dave Ryan talks with members of the Cancer Center’s nursing leadership and discuss how the COVID-19 crisis has changed what they do in their units on a day-to-day basis, what the "new normal" will look like moving forward, and what they are grateful for during this time.
Dr. Ryan talks with the Cancer Center’s ambulatory nursing leadership and discuss how the COVID-19 crisis impacted their separate units, how they have responded during this time, the stressors they face, and how all of the amazing nurses and APPs have stepped up for patients and each other.
Dr. Eric Rosenberg discusses testing for COVID-19, the two types of tests that are currently available, and advice for the Cancer Center population in order to minimize risk from COVID-19.
Dr. Alyssa Letourneau discusses the antiviral Remdesivir, how it was developed, and the clinical trials that are taking place to test the drug.
Dr. Lennes discusses her role as part of Mass General's Hospital Incident Command System (HICS) and how HICS was activated in response to the COVID-19 pandemic.
Dr. Hong and Dr. Qadan discuss how the Cancer Center has had to postpone some cancer surgeries due to the COVID-19 pandemic, how these patients are being managed and how the Cancer Center is prioritizing each and every patient going forward.
Dr. David Ryan chats with Dr. Keith Flaherty, Director of Clinical Research. Dr. Flaherty describes his current role as leader of Mass General's team of experts reviewing possible coronavirus-related clinical trials, and discusses what the implications are for cancer research going forward.
Dr. Ryan chats with Dr. Kerry Reynolds, Clinical Director of the Inpatient Oncology Units at the Cancer Center. Dr. Reynolds describes what it was like to run the inpatient service pre-COVID, how it all changed in March 2020, and how the experience has changed her personally.
In this video, Dr. David Ryan chats with Dr. Inga Lennes, Senior Vice President for Service Excellence and Practice Improvement at the Massachusetts General Physicians Organization, as well as a lung cancer physician at the Mass General Cancer Center.
In this video, Dr. Eric Rosenberg discusses testing for COVID-19, the two types of tests that are currently available, and advice for the Cancer Center population in order to minimize risk from COVID-19.
In this video, Dr. Alyssa Letourneau discusses the antiviral Remdesivir, how it was developed, and the clinical trials that are taking place to test the drug.
Dr. Hong and Dr. Qadan discuss how the Cancer Center has had to postpone some cancer surgeries due to the COVID-19 pandemic, how these patients are being managed and how the Cancer Center is prioritizing each and every patient going forward.
In this video, Dr. David Ryan chats with Dr. Keith Flaherty, Director of Clinical Research at the Cancer Center.
In this video, Dr. David Ryan chats with Dr. Kerry Reynolds, Clinical Director of the Inpatient Oncology Units at the Cancer Center.
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.
